del Campo Ralph 4
4 · ENZON PHARMACEUTICALS INC · Filed Jan 28, 2011
Insider Transaction Report
Form 4
del Campo Ralph
EVP, Technical Operations
Transactions
- Other
Common Stock
2011-01-17+18,333→ 171,216.136 total - Tax Payment
Common Stock
2011-01-17$12.15/sh−6,802$82,644→ 164,414.136 total - Other
Common Stock
2011-01-27+12,665→ 164,414.136 total - Tax Payment
Common Stock
2011-01-27$11.63/sh−4,744$55,173→ 159,670.136 total
Footnotes (6)
- [F1]Shares acquired upon vesting of restricted stock granted to the Reporting Person on January 17, 2008 and reported on a Form 4 filed on January 18, 2008.
- [F2]The Reporting Person previously reported all restricted stock granted to the Reporting Person on January 17, 2008 in Table I of the Form 4 filed on January 18, 2008. As such, no adjustment to the Reporting Person's beneficial ownership needs to be made to reflect this vesting event.
- [F3]Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the restricted stock described in this Form 4.
- [F4]Shares acquired upon vesting of restricted stock units granted to the Reporting Person on January 27, 2010 and reported on a Form 4 filed on January 29, 2010.
- [F5]The Reporting Person previously reported all restricted stock units granted to the Reporting Person on January 27, 2010 in Table I of the Form 4 filed on January 29, 2010. As such, no adjustment to the Reporting Person's beneficial ownership needs to be made to reflect this vesting event.
- [F6]Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the restricted stock units described in this Form 4.